[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:bacterial-infection":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":74,"states":75},"Bacterial Infection",10,8,[8,16,23,29,35,41,47,54,60,67],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06709521","Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)",[12],"Phase 4","RECRUITING","2026-08-03T00:58:41.868343Z","2026-07-05T05:32:16.693680Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07092813","Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents",[20],"Phase 1","2026-08-26T02:17:45.190188Z","2026-05-05T02:43:27.275791Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07104162","A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol\u002FXeruborbactam in Participants With Renal Impairment",[20],"2026-08-26T02:19:27.519777Z","2026-04-29T02:57:57.106087Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06824350","Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates",[],"2026-08-26T02:17:15.156099Z","2026-05-05T02:43:27.811244Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07076238","Biomarkers of Phage Treatment Response in NTM and Other Infections",[],"2026-08-26T02:15:21.365312Z","2026-05-13T02:55:06.649803Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT01904188","Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?",[],"2026-08-26T02:18:58.141497Z","2026-07-05T05:32:16.768771Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT06414408","Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP",[51],"Early Phase 1","2026-08-26T02:15:33.331531Z","2026-05-05T02:43:27.992067Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT04263792","[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET\u002FCT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects",[20],"2026-08-26T02:18:11.042248Z","2026-05-05T02:35:31.909785Z",{"nct_id":61,"title":62,"phases":63,"status":64,"updated_at":65,"content_modified":66},"NCT05314426","Mayo Clinic Phage Program Biobank",[],"ENROLLING_BY_INVITATION","2026-08-26T02:18:09.641312Z","2026-06-16T05:54:08.028894Z",{"nct_id":68,"title":69,"phases":70,"status":71,"updated_at":72,"content_modified":73},"NCT05817825","Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD",[],"UNKNOWN","2026-08-03T02:29:52.097456Z","2026-05-05T02:43:29.465223Z",[],[76],{"state":77,"count":78,"slug":79},"California",3,"california"]